Medical News

RSS

Developing nations: Laboratories for health care innovation

Kaiser Health News staff writer Jaclyn Schiff writes: A few months ago, GE Healthcare rolled out a portable electrocardiogram machine, trumpeting the new product's ability to help patients wherever they might need it.

9 Apr 2010

DISH should be considered an important cause of dysphagia among older adults: Study

Diffuse idiopathic skeletal hyperostosis is a common but often unrecognized systemic disorder observed mainly in elderly people. All papers related to DISH demonstrate a consistent and marked increase of the disease with advancing age. Various local structural lesions such as oropharyngeal tumors, vascular pathologies, retropharyngeal abscesses, and anterior cervical osteophytes may lead to mechanical esophageal dysphagia.

9 Apr 2010

Community health centers eagerly await funding from reform law

The Squirrel Hill Health Center in Pittsburgh is one of many community health centers that will see a significant funding increase under the health overhaul law, according to the Pittsburgh Post-Gazette.

9 Apr 2010

Critical experts introduce mild exercise programs to care critically ill patients in ICU

A new report from critical care experts at Johns Hopkins shows that use of prescription sedatives goes down by half so that mild exercise programs can be introduced to the care of critically ill patients in the intensive care unit.

9 Apr 2010

New CMS dashboard powered by MicroStrategy

MicroStrategy® Incorporated, a leading worldwide provider of business intelligence software, today announced that the new information dashboard recently launched by the Centers for Medicare & Medicaid Services is powered by MicroStrategy.

9 Apr 2010

Latest advancement in the development of lab tests for bipolar disorder

Genetic testing may rise to a new level with the findings of Indiana University School of Medicine researchers whose "prototype" for laboratory testing for bipolar disorder appears today in the online edition of the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.

9 Apr 2010

Gamma-tocotrienol kills prostate tumour cells in animal model studies

Researchers from Davos Life Science in Singapore, in collaboration with scientists at the University of Hong Kong, have shown that gamma-tocotrienol, a member of the vitamin E family, is potent in killing prostate tumour cells in animal model studies. This research was reported this week in the latest edition of Pharmacology.

9 Apr 2010

Level of bacteria on fresh produce can vary according to income level: Study

No one wants a mixed salad tossed with extra bacteria, mold and yeast, but those are just what you might find when you try to eat a healthier diet in poorer neighborhoods. A new study shows that the level of bacteria found on the fresh produce can vary according to the income level of the neighborhoods where it is for sale.

9 Apr 2010

World Vision to construct transitional shelters for displaced Haitians

World Vision is supporting the first relocation of 7,500 displaced Haitians from camps in Port-au-Prince to a site on the outskirts of the city where transitional shelters will be built. In partnership with other agencies, World Vision will construct one-third of the 1,356 shelters planned for a 75 sq. kilometre plot of land recently allocated by the Government of Haiti for people most at risk from the upcoming rainy season.

9 Apr 2010

The Kids Food Adventure with Chef Jehangir Mehta created to promote positive eating habits for children

Whole Foods Market, the leading natural and organic foods supermarket, and Chef Jehangir Mehta, "The Next Iron Chef" runner-up and executive chef/owner of Graffiti Food & Wine Bar in New York City, have joined forces to create The Kids Food Adventure with Chef Jehangir Mehta, a series of hands-on classes to encourage parents and children to be more adventurous with food while making healthy choices.

9 Apr 2010

Catalyst Pharmaceutical Partners' vigabatrin data to be presented at 41st ASAM conference

Catalyst Pharmaceutical Partners, Inc. today announced that on Friday April 16th, Eugene C. Somoza, MD, PhD, University of Cincinnati College of Medicine and VA Medical Center, Cincinnati, OH will present a paper he authored along with Charles Gorodetzky, MD, PhD, Douglas Winship and Peggy Somoza, entitled: "A Multi-Site, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Vigabatrin (VGB) for Treating Cocaine Dependence"

9 Apr 2010

TriLink partners with Cedarlane to enhance distribution of its products in Canada

TriLink BioTechnologies, has entered into an agreement with Cedarlane Corporation, a Canadian based research biotechnology company, for the sale and distribution of its modified nucleoside triphosphates, custom chemistry and oligonucleotide products.

9 Apr 2010

Cephalon acquires Mepha

Cephalon, Inc. announced that it has today completed its previously announced acquisition of Mepha, the Swiss-based pharmaceutical company. As a result of the acquisition, Mepha is now a wholly-owned subsidiary of Cephalon. The purchase price paid at closing, inclusive of certain closing adjustments, was CHF 662.4 million (or approximately US$615.4 million). The purchase price is also subject to further post-closing working capital and net debt adjustments.

9 Apr 2010

KHN Column: Can Massachusetts' experiment tell us what's next?

In his latest Kaiser Health News column, James Capretta writes: "Now that the year-long debate in Congress over health care legislation has come to a close, it's reasonable to ask: What's next?"

9 Apr 2010

Penwest Pharmaceuticals signs drug development and commercialization agreement with Alvogen

Penwest Pharmaceuticals Co. today announced that it has signed a drug development and commercialization agreement with Alvogen, Inc. under which Penwest and Alvogen have agreed to identify and select up to five compounds for generic development. Penwest's TIMERx technology may be used for each compound selected.

9 Apr 2010

More public-private partnerships crucial for success of Italian pharmaceutical industry

The newly retired Chief Executive Officer of Roche Pharmaceuticals Bill Burns today led calls for more public-private partnerships in the pharmaceutical industry at the launch of the Italian Institute of Technology's Drug Discovery and Development Unit (D3).

9 Apr 2010

Hospitalists shape the future of American healthcare system

On March 21, 2010, Congress passed the most comprehensive healthcare reform bill since the formation of Medicare. While a monumental achievement, the bill leaves much of the critical work of healthcare reform unfinished, according to a new editorial by Dr. Robert Wachter, Chief of the Division of Hospital Medicine, University of California, San Francisco, and past president of the Society of Hospital Medicine, in the April issue of the Journal of Hospital Medicine.

9 Apr 2010

Tβ4 therapy for ocular disorders closer to reality

RegeneRx Biopharmaceuticals, Inc. announced today that Tβ4, a synthetic version of a naturally occurring peptide that is the basis for the company's product candidates, will be the subject of three poster presentations at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) to be held in Fort Lauderdale, Florida from May 2-6, 2010.

9 Apr 2010

Broken heart disease affects women in post menopause period

It seems an infarction, but it's not. It's called Tako-Tsubo syndrome, or stress-induced cardiomyopathy, and it's a rare disease which at first used to be confused with the far more common (and dangerous) cardiac infarction. Patients arrive to the emergency room with the characteristic heart attack symptoms: acute pain in the chest, an electrocardiogram with the typical changes and the release of those enzymes associated with the usual heart disease.

9 Apr 2010

A*STAR announces fifth major collaboration with Italian research centres and universities

Two research units under Singapore's Agency for Science, Technology and Research (A*STAR), the Experimental Therapeutics Centre (ETC) and Singapore Immunology Network (SIgN), are collaborating with Italy's Siena Biotech S.p.A. to develop new drugs and targeted antibodies respectively, which will potentially help millions of cancer and bone loss patients across the world. This is the fifth major collaboration A*STAR has with research centres and universities in Italy .

9 Apr 2010

Medical News

Developing nations: Laboratories for health care innovation

DISH should be considered an important cause of dysphagia among older adults: Study

Community health centers eagerly await funding from reform law

Critical experts introduce mild exercise programs to care critically ill patients in ICU

New CMS dashboard powered by MicroStrategy

Latest advancement in the development of lab tests for bipolar disorder

Gamma-tocotrienol kills prostate tumour cells in animal model studies

Level of bacteria on fresh produce can vary according to income level: Study

World Vision to construct transitional shelters for displaced Haitians

The Kids Food Adventure with Chef Jehangir Mehta created to promote positive eating habits for children

Catalyst Pharmaceutical Partners' vigabatrin data to be presented at 41st ASAM conference

TriLink partners with Cedarlane to enhance distribution of its products in Canada

Cephalon acquires Mepha

KHN Column: Can Massachusetts' experiment tell us what's next?

Penwest Pharmaceuticals signs drug development and commercialization agreement with Alvogen

More public-private partnerships crucial for success of Italian pharmaceutical industry

Hospitalists shape the future of American healthcare system

Tβ4 therapy for ocular disorders closer to reality

Broken heart disease affects women in post menopause period

A*STAR announces fifth major collaboration with Italian research centres and universities

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News